Clinical Trials
2 trialsNCT06003673 2023-10-24
A Clinical Study of Tislelizumab Combined With TACE and Lenvatinib in the Neoadjuvant Treatment of Resectable HCC
First Affiliated Hospital of Fujian Medical University
Phase 4 Unknown
NCT01868828 2013-06-06
A Study of PAD Versus Velcade, Cyclophosphamide and Dexamethasone (VCD) Treatment in Subjects With Multiple Myeloma
Peking University People's Hospital
Phase 4 Unknown